Finding 481113 (2022-004)

Material Weakness Repeat Finding
Requirement
L
Questioned Costs
-
Year
2022
Accepted
2024-08-15
Audit: 317252
Organization: Unity Health Care, Inc. (MD)
Auditor: Bdo USA PC

AI Summary

  • Core Issue: The audit and related documents for 2022 were not submitted by the September 30, 2023 deadline, and the SEFA was not prepared accurately or on time.
  • Impacted Requirements: This violates 2 CFR Section 200.512(a), which mandates timely submission of audit reports and accurate SEFA preparation.
  • Recommended Follow-Up: Implement formal policies and procedures to track reporting requirements and ensure timely, accurate preparation and submission of all necessary documents.

Finding Text

Criteria: In accordance with 2 CFR Section 200.512(a), the audit must be completed and data collection form and reporting package must be submitted within the earlier of 30 calendar days after receipt of the auditor’s report(s), or nine months after the end of the audit period, adjusted for any extensions permitted by the Office of Management and Budget. Additionally, management is required to prepare a complete and accurate SEFA. Condition: We noted that the audit, reporting package, and data collection form for the year ended December 31, 2022, were not filed by the deadline of September 30, 2023, to the Federal Audit Clearinghouse. Additionally, the SEFA was not accurately, completely, and timely prepared. Cause: The Corporation did not have a formal process in place during the year ended December 31, 2022, to accurately, completely, and timely prepare the SEFA. Effect or Potential Effect: The audit, reporting package, and data collection form for the year ended December 31, 2022, were not accessible to the Federal Audit Clearinghouse in a timely manner and the SEFA was not timely, accurately, or completely prepared. Questioned costs: None Context: The audit, reporting package, and data collection form for the year ended December 31, 2022, was filed untimely to the Federal Audit Clearinghouse. Repeat finding: This is a repeat finding from prior year. This was reported as finding 2021-004 in the 2021 report. Recommendation: We recommend the Corporation adopt policies and procedures, including tracking and monitoring of reporting requirements, to ensure that the SEFA is timely, accurately, and completely prepare and that the audit, reporting package, and data collection form are electronically filed with the Federal Audit Clearinghouse within the applicable deadline. View of Responsible Officials: Due to turnover of several key financial executives and personnel and lack of formal documentation of current policies and procedures, the Corporation was unable to timely prepare the SEFA and related audit documentation.

Corrective Action Plan

Management Response #2022-004: Due to staff shortages and turnover in FY2020-21 and continuing into FY2022, the company did not have adequate personnel in place to properly monitor or document grant activity. Formal documentation of policies and procedures were also deficient. Corrective Action Plan: The following action items have been established. • In 2022, the finance team delineated and expanded positions whose primary responsibility is to monitor and manage all grant activities. • In 2022 Project Budget Reports have been created for each federal award. These reports include the budget, expenses foreach month and the revenue (drawdown) incurred foreach month. The reports will be reviewed and reconciled by the grants administration staff and finance monthly to ensure all agree with the allocated costs and that costs follow compliance and grant regulations. This will allow timely reconciliation of grants before year end for FFRs, SEFA preparation, audit, reporting package and data collection for FAC. Responsible Party: Tamara Barnes, CFO

Categories

Reporting

Other Findings in this Audit

  • 481114 2022-005
    Material Weakness Repeat
  • 481115 2022-006
    Material Weakness Repeat
  • 481116 2022-007
    Significant Deficiency Repeat
  • 481117 2022-009
    Material Weakness Repeat
  • 481118 2022-010
    Significant Deficiency Repeat
  • 481119 2022-011
    Significant Deficiency Repeat
  • 481120 2022-004
    Material Weakness Repeat
  • 481121 2022-005
    Material Weakness Repeat
  • 481122 2022-006
    Material Weakness Repeat
  • 481123 2022-007
    Significant Deficiency Repeat
  • 481124 2022-009
    Material Weakness Repeat
  • 481125 2022-010
    Significant Deficiency Repeat
  • 481126 2022-011
    Significant Deficiency Repeat
  • 481127 2022-004
    Material Weakness Repeat
  • 481128 2022-005
    Material Weakness Repeat
  • 481129 2022-006
    Material Weakness Repeat
  • 481130 2022-007
    Significant Deficiency Repeat
  • 481131 2022-012
    Significant Deficiency
  • 481132 2022-013
    Significant Deficiency
  • 481133 2022-016
    Significant Deficiency
  • 481134 2022-017
    Significant Deficiency
  • 481135 2022-004
    Material Weakness Repeat
  • 481136 2022-005
    Material Weakness Repeat
  • 481137 2022-006
    Material Weakness Repeat
  • 481138 2022-008
    Significant Deficiency Repeat
  • 481139 2022-009
    Material Weakness Repeat
  • 481140 2022-016
    Significant Deficiency
  • 481141 2022-004
    Material Weakness Repeat
  • 481142 2022-005
    Material Weakness Repeat
  • 481143 2022-006
    Material Weakness Repeat
  • 481144 2022-007
    Significant Deficiency Repeat
  • 481145 2022-016
    Significant Deficiency
  • 481146 2022-004
    Material Weakness Repeat
  • 481147 2022-005
    Material Weakness Repeat
  • 481148 2022-006
    Material Weakness Repeat
  • 481149 2022-010
    Significant Deficiency Repeat
  • 481150 2022-014
    Material Weakness
  • 481151 2022-015
    Significant Deficiency
  • 481152 2022-016
    Significant Deficiency
  • 1057555 2022-004
    Material Weakness Repeat
  • 1057556 2022-005
    Material Weakness Repeat
  • 1057557 2022-006
    Material Weakness Repeat
  • 1057558 2022-007
    Significant Deficiency Repeat
  • 1057559 2022-009
    Material Weakness Repeat
  • 1057560 2022-010
    Significant Deficiency Repeat
  • 1057561 2022-011
    Significant Deficiency Repeat
  • 1057562 2022-004
    Material Weakness Repeat
  • 1057563 2022-005
    Material Weakness Repeat
  • 1057564 2022-006
    Material Weakness Repeat
  • 1057565 2022-007
    Significant Deficiency Repeat
  • 1057566 2022-009
    Material Weakness Repeat
  • 1057567 2022-010
    Significant Deficiency Repeat
  • 1057568 2022-011
    Significant Deficiency Repeat
  • 1057569 2022-004
    Material Weakness Repeat
  • 1057570 2022-005
    Material Weakness Repeat
  • 1057571 2022-006
    Material Weakness Repeat
  • 1057572 2022-007
    Significant Deficiency Repeat
  • 1057573 2022-012
    Significant Deficiency
  • 1057574 2022-013
    Significant Deficiency
  • 1057575 2022-016
    Significant Deficiency
  • 1057576 2022-017
    Significant Deficiency
  • 1057577 2022-004
    Material Weakness Repeat
  • 1057578 2022-005
    Material Weakness Repeat
  • 1057579 2022-006
    Material Weakness Repeat
  • 1057580 2022-008
    Significant Deficiency Repeat
  • 1057581 2022-009
    Material Weakness Repeat
  • 1057582 2022-016
    Significant Deficiency
  • 1057583 2022-004
    Material Weakness Repeat
  • 1057584 2022-005
    Material Weakness Repeat
  • 1057585 2022-006
    Material Weakness Repeat
  • 1057586 2022-007
    Significant Deficiency Repeat
  • 1057587 2022-016
    Significant Deficiency
  • 1057588 2022-004
    Material Weakness Repeat
  • 1057589 2022-005
    Material Weakness Repeat
  • 1057590 2022-006
    Material Weakness Repeat
  • 1057591 2022-010
    Significant Deficiency Repeat
  • 1057592 2022-014
    Material Weakness
  • 1057593 2022-015
    Significant Deficiency
  • 1057594 2022-016
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $4.41M
93.788 Opioid Str $1.46M
93.217 Family Planning_services $1.34M
10.557 Special Supplemental Nutrition Program for Women, Infants, and Children $1.29M
93.914 Hiv Emergency Relief Project Grants $898,253
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $584,947
93.837 Cardiovascular Diseases Research $402,416
93.917 Hiv Care Formula Grants $367,131
93.426 Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke $178,078
93.994 Maternal and Child Health Services Block Grant to the States $169,521
93.268 Immunization Cooperative Agreements $167,318
93.236 Grants to States to Support Oral Health Workforce Activities $104,190
93.898 Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations $81,214
93.526 Affordable Care Act (aca) Grants for Capital Development in Health Centers $77,935
93.889 National Bioterrorism Hospital Preparedness Program $33,398
93.279 Drug Abuse and Addiction Research Programs $31,446
93.297 Teenage Pregnancy Prevention Program $14,271
93.855 Allergy, Immunology and Transplantation Research $1,571